SCHEMBL18459587

SCHEMBL18459587

CCc1cc(Br)c(CNC(C)(C)C)cc1CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 2/20 0.37
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36
GAA P10253 2/20 0.36
HIF1A Q16665 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA2 P00918 2/20 0.33
TP53BP1 Q12888 1/20 0.32
RIPK1 Q13546 1/20 0.32
HDAC1 Q13547 1/20 0.32
CYP2D6 P10635 1/20 0.31
GABRA1 P14867 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL901909 0.77 MEN1 (0.41) KMT2AMEN1HTTKDM4EALDH1A1
SCHEMBL11807767 0.71 GABRA1 (0.46) ALOX15HSD17B10GABRA1GABRB2LMNA
SCHEMBL21795251 0.70 MAPT (0.42) KMT2AMEN1HTTKDM4EALDH1A1
SCHEMBL26156490 0.69 KDM4E (0.47) KMT2AMEN1HTTKDM4EALDH1A1
SCHEMBL21884099 0.69 GABRA1 (0.43) HTTALOX15HSD17B10GABRA1GABRB2
SCHEMBL15961518 0.68 RIPK1 (0.51) KMT2AMEN1HTTKDM4EALDH1A1
SCHEMBL11591624 0.67 MEN1 (0.50) KMT2AMEN1HTTALDH1A1HPGD
SCHEMBL10799329 0.67 GABRA1 (0.42) ALOX15GABRA1GABRB2LMNA
Hydrochloric Acid SCHEMBL11592148 0.66 MEN1 (0.49) KMT2AMEN1HTTALDH1A1NPY1R
SCHEMBL27642496 0.65 HSPA5 (0.49) KMT2AMEN1HTTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017017043-A1 NOVEL 6,7-DIHYDROPYRIDO[2,1-A]PHTHALAZIN-2-ONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2017-02-02 WO disclosed